Ticker >

Titan Bio-Tech share price

Titan Bio-Tech Ltd.

BSE: 524717 SECTOR: Chemicals  62k   828   84

509.05
+13.50 (2.72%)
BSE: 26 Apr 04:01 PM

Price Summary

Today's High

₹ 515

Today's Low

₹ 500

52 Week High

₹ 618

52 Week Low

₹ 228.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

420.66 Cr.

Enterprise Value

422.8 Cr.

No. of Shares

0.83 Cr.

P/E

17.93

P/B

3.41

Face Value

₹ 10

Div. Yield

0.35 %

Book Value (TTM)

₹  149.4

CASH

4.86 Cr.

DEBT

7 Cr.

Promoter Holding

55.88 %

EPS (TTM)

₹  28.39

Sales Growth

16.55%

ROE

21.86 %

ROCE

27.9%

Profit Growth

-3.04 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year16.55%
3 Year27.5%
5 Year20.99%

Profit Growth

1 Year-3.04%
3 Year50.23%
5 Year54.33%

ROE%

1 Year21.86%
3 Year35.3%
5 Year26.96%

ROCE %

1 Year27.9%
3 Year41.67%
5 Year31.23%

Debt/Equity

0.066

Price to Cash Flow

19.86

Interest Cover Ratio

38.6940608660678

CFO/PAT (5 Yr. Avg.)

0.915361588595476

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 55.88 0
Dec 2023 55.88 0
Sep 2023 55.88 0
Jun 2023 55.88 0
Mar 2023 55.88 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 50.2266371984293% for the Past 3 years.
  • The company has shown a good revenue growth of 27.4989789778163% for the Past 3 years.
  • Company has been maintaining healthy ROE of 35.3034250203555% over the past 3 years.
  • Company has been maintaining healthy ROCE of 41.6727674285502% over the past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 38.6940608660678.
  • The Company has been maintaining an effective average operating margins of 21.6930741127486% in the last 5 years.
  • Company has a healthy liquidity position with current ratio of 2.74152570071397.
  • The company has a high promoter holding of 55.88%.

 Limitations

 Looks like the company does not have any serious limitations.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 30.33 36.84 34.75 43.43 45.98
Total Expenditure 26.2 30.01 26.86 34.71 35.38
Operating Profit 4.14 6.83 7.89 8.71 10.6
Other Income 0.28 0.49 0.28 0.55 0.44
Interest 0.14 0.26 0.29 0.28 0.26
Depreciation 0.65 0.71 0.8 0.86 0.84
Exceptional Items 0 0 0 0 0
Profit Before Tax 3.63 6.36 7.09 8.13 9.94
Tax 0.93 1.71 1.68 2.1 2.56
Profit After Tax 2.7 4.64 5.41 6.03 7.38
Adjusted EPS (Rs) 3.27 5.62 6.55 7.29 8.94

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 58.24 69.48 122.46 123.55 144
Total Expenditure 50.78 58.6 80.59 92.28 114.48
Operating Profit 7.46 10.88 41.87 31.27 29.52
Other Income 0.65 0.41 0.66 0.94 1.94
Interest 2.08 1.91 1.33 0.87 0.75
Depreciation 1.68 1.75 2.1 2.37 2.6
Exceptional Items 0 0.61 -0.32 0 0
Profit Before Tax 4.36 8.24 38.76 28.97 28.12
Tax 1.28 2.04 9.99 7.28 7.09
Net Profit 3.08 6.2 28.77 21.68 21.02
Adjusted EPS (Rs.) 3.73 7.5 34.82 26.24 25.44

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 8.26 8.26 8.26 8.26 8.26
Total Reserves 23.4 29.55 57.56 77.98 97.83
Borrowings 12.02 8.48 1.83 1.08 0.3
Other N/C liabilities 1.98 2.44 3.99 3.82 3.95
Current liabilities 15.11 17.93 24.3 23.99 27.54
Total Liabilities 60.76 66.66 95.94 115.13 137.88
Assets
Net Block 25.9 25.24 27.04 34.99 35.89
Capital WIP 0 0 0.27 3.63 13.29
Intangible WIP 0 0 0 0 0
Investments 1.27 1.27 1.27 4.03 11.59
Loans & Advances 0.56 0.58 7.77 1.52 1.35
Other N/C Assets 0 0 0.18 0.16 0.26
Current Assets 33.02 39.57 59.4 70.79 75.49
Total Assets 60.76 66.66 95.94 115.13 137.88
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 4.36 8.24 38.76 28.97 28.12
Adjustment 3.91 3.86 3.62 3.52 3.69
Changes in Assets & Liabilities -1.12 -3.64 -14.64 -3.33 -3.13
Tax Paid -0.95 -1.54 -10.16 -7.12 -7.5
Operating Cash Flow 6.2 6.92 17.59 22.04 21.18
Investing Cash Flow -3.74 -0.94 -4.17 -16.44 -20.73
Financing Cash Flow -1.55 -5.87 -9.81 -4.1 -2.4
Net Cash Flow 0.9 0.11 3.61 1.51 -1.95

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 55.88 55.88 55.88 55.88 55.88
connoisseur management se... 6.78 6.78 6.78 6.78 6.78
madhu gupta 0.80 0.80 0.80 0.80 0.80
manju singla 0.86 0.86 0.86 0.86 0.86
naresh kumar singla 0.42 0.42 0.42 0.42 0.42
naresh kumar singla huf 0.12 0.12 0.12 0.12 0.12
raja singla 0.74 0.74 0.74 0.74 0.74
ravinder gupta 0.10 0.10 0.10 0.10 0.10
shivom singla 0.43 0.43 0.43 0.43 0.43
supriya singla 0.66 0.66 0.66 0.66 0.66
suresh chand singla 1.28 1.28 1.28 1.28 1.28
tanita leasing & finance ... 9.49 9.49 9.49 9.49 9.49
titan securities ltd 33.59 33.59 33.59 33.59 33.59
udit singla 0.61 0.61 0.61 0.61 0.61
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 44.12 44.12 44.12 44.12 44.12
investor education and pr... 8.27 8.26 8.25 - 8.81
mukesh panjwani - - - 1.03 1.13
investor education and pr... - - - 8.81 -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

Titan Biotech informs about certificate6 Apr 2024, 12:07PM Titan Biotech informs about issue of duplicate share certificate5 Mar 2024, 5:14PM Titan Biotech to acquire stake in Titan Media12 Feb 2024, 5:14PM Titan Bio-Tech - Quaterly Results12 Feb 2024, 3:44PM Titan Bio-Tech - Quaterly Results12 Feb 2024, 3:44PM Titan Bio-Tech - Quaterly Results12 Feb 2024, 3:44PM Titan Biotech informs about details of loss of certificate24 Nov 2023, 5:04PM Titan Biotech informs about loss of shareholder certificate 31 Oct 2023, 5:11PM Titan Bio-Tech - Quaterly Results10 Aug 2023, 3:46PM Titan Bio-Tech - Quaterly Results10 Aug 2023, 3:46PM Titan Biotech informs about details of loss of certificate4 Aug 2023, 4:46PM Titan Biotech informs about compliance certificate7 Jul 2023, 5:27PM Titan Bio-Tech - Quaterly Results29 May 2023, 3:54PM Titan Bio-Tech - Quaterly Results29 May 2023, 3:54PM Titan Biotech informs about loss of share certificate 10 Apr 2023, 5:03PM Titan Biotech informs about issuance of duplicate share certificate23 Mar 2023, 12:16PM Titan Biotech informs about loss of share certificate 21 Mar 2023, 11:42AM Titan Bio-Tech - Quaterly Results4 Feb 2023, 4:05PM Titan Bio-Tech - Quaterly Results4 Feb 2023, 4:05PM Titan Bio-Tech - Quaterly Results4 Feb 2023, 4:05PM Titan Biotech informs about board meeting 27 Jan 2023, 12:41PM Titan Biotech informs about certificate7 Jan 2023, 12:17PM Titan Biotech informs about issuance of duplicate share certificates26 Nov 2022, 12:31PM Titan Bio-tech informs about loss of share certificate 17 Nov 2022, 12:47PM Titan Bio-Tech - Quaterly Results14 Nov 2022, 3:34PM Titan Biotech informs about details of loss of certificate 16 Aug 2022, 2:44PM Titan Bio-Tech - Quaterly Results10 Aug 2022, 5:38PM Titan Biotech informs about compliances-certificate13 Jul 2022, 4:19PM Titan Biotech informs about newspaper publication2 Jul 2022, 1:54PM Titan Biotech informs about issuance of duplicate share certificate25 Jun 2022, 11:23AM Titan Biotech informs about issue of duplicate certificates14 Jun 2022, 5:01PM Titan Biotech informs about issue of duplicate certificate8 Jun 2022, 2:31PM Titan Biotech informs about loss of share certificate18 May 2022, 5:02PM Titan Bio-tech informs about issuance of duplicate share certificate25 Apr 2022, 5:02PM Titan Bio-Tech - Quaterly Results9 Feb 2022, 3:33PM Titan Bio-Tech - Quaterly Results9 Feb 2022, 3:33PM Titan Bio-Tech - Quaterly Results9 Feb 2022, 3:33PM Titan Biotech informs about issuance of duplicate share certificate 22 Dec 2021, 12:13PM Titan Biotech informs about board meeting1 Nov 2021, 4:20PM Titan Biotech informs about issue of duplicate share certificate18 Oct 2021, 4:35PM Titan Biotech informs about proceedings of AGM25 Sep 2021, 2:52PM Titan Biotech informs about loss of share certificate8 Jul 2021, 2:36PM Titan Bio-Tech informs about independent directors meet18 Mar 2021, 11:29AM Titan Bio-Tech informs about disclosure2 Mar 2021, 3:58PM Titan Bio-Tech informs about newspaper advertisements 27 Aug 2020, 5:12PM Titan Bio-tech informs about 28th AGM24 Aug 2020, 3:39PM Titan Biotech informs about board meeting20 Jun 2020, 4:06PM

Titan Bio-Tech Stock Price Analysis and Quick Research Report. Is Titan Bio-Tech an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). Titan Bio-Tech has a PE ratio of 17.9280202577296 which is high and comparatively overvalued .

  • Share Price: - The current share price of Titan Bio-Tech is Rs 509.05. One can use valuation calculators of ticker to know if Titan Bio-Tech share price is undervalued or overvalued.

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Titan Bio-Tech has ROA of 16.619764625532 % which is a good sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Titan Bio-Tech has a Current ratio of 2.74152570071397 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Titan Bio-Tech has a ROE of 21.8626079297811 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. Titan Bio-Tech has a D/E ratio of 0.066 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. Titan Bio-Tech has an Inventory turnover ratio of 4.06494630151603 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - Titan Bio-Tech has reported revenue growth of 16.5524743644015 % which is fair in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of Titan Bio-Tech for the current financial year is 20.499544095006 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Titan Bio-Tech is Rs 1.8 and the yield is 0.3555 %.

Last Updated on:
Brief about Titan Bio-Tech
X